No, lack of transparency forward guidance on revenue streams, no profit taking, lol, systematically being shorted due to the unknowns, e.g. assay results outstanding, resource upgrades, lom extention update, balance sheet for Q2, difficulty bringing on BP33, cost of developing, but I believe this year Gareth will be able to successfully address these.
No, lack of transparency forward guidance on revenue streams, no...
-
- There are more pages in this discussion • 1,300 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CXO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.3¢ |
Change
-0.005(5.10%) |
Mkt cap ! $198.7M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.0¢ | 9.3¢ | $3.295M | 34.70M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 365887 | 9.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.4¢ | 883409 | 8 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CXO (ASX) Chart |